Loading...

APC/Cyanine7 anti-mouse CD8a Antibody APC/Cyanine7 anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
    C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100714 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100713 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  2. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  3. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  4. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  5. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  6. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  7. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  8. Ke F, et al. 2023. Elife. 12:. PubMed
  9. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  10. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  11. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  12. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  13. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  14. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  15. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  16. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  17. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  18. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  19. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  20. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  21. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  22. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  23. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  24. Qu L, et al. 2022. Cell. 185:1728. PubMed
  25. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  26. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  27. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  28. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  29. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  30. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  31. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  32. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  33. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  34. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  35. Elazar A, et al. 2022. Elife. 11:. PubMed
  36. Berube A, et al. 2022. Viruses. 14:. PubMed
  37. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  38. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  39. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  40. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  41. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  42. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  43. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  44. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  45. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  46. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  47. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  48. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  49. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  50. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  51. Chen J, et al. 2008. Blood. 111:5163. PubMed
  52. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  53. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  54. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  55. Wei H, et al. 2021. Malar J. 20:89. PubMed
  56. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  57. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  58. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  59. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  60. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  61. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  62. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  63. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  64. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  65. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  66. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  67. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  68. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  69. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  70. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  71. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  72. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  73. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  74. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  75. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  76. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  77. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  78. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  79. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  80. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  81. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  82. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  83. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  84. Das S, et al. 2019. Oncogene. 383316. PubMed
  85. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  86. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  87. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  88. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  89. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  90. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  91. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  92. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  93. Marangoni F, et al. 2021. Cell. . PubMed
  94. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  95. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  96. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  97. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  98. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  99. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  100. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  101. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  102. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  103. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  104. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  105. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  106. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  107. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  108. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  109. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  110. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  111. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  112. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  113. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  114. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  115. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  116. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  117. Zheng J, et al. 2020. bioRxiv. . PubMed
  118. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  119. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  120. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  121. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  122. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  123. França TT, et al. 2021. JCI Insight. 6:. PubMed
  124. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  125. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  126. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  127. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  128. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  129. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  130. Zheng J, et al. 2020. Nature. . PubMed
  131. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  132. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  133. Gough D, et al. 2014. Blood. 124:2252. PubMed
  134. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  135. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  136. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  137. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  138. Giampazolias E, et al. 2021. Cell. . PubMed
  139. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  140. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  141. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  142. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  143. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  144. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  145. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  146. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  147. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  148. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  149. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  150. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  151. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  152. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  153. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  154. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  155. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  156. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  157. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  158. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  159. Koide S, et al. 2022. iScience. 25:103603. PubMed
  160. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  161. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  162. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  163. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  164. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  165. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  166. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  167. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  168. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  169. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  170. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  171. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  172. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  173. Li H, et al. 2022. iScience. 25:104481. PubMed
  174. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  175. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  176. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  177. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  178. Zhang B, et al. 2021. Nature. 599:471. PubMed
  179. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  180. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  181. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  182. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  183. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  184. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  185. Yang H, et al. 2022. Viruses. 14:. PubMed
  186. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  187. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  188. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  189. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  190. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  191. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  192. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  193. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  194. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  195. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  196. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  197. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  198. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  199. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  200. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  201. Ke F, et al. 2023. Elife. 12:. PubMed
  202. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  203. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  204. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  205. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  206. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  207. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  208. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  209. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  210. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  211. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  212. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  213. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  214. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  215. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  216. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  217. Qu L, et al. 2022. Cell. 185:1728. PubMed
  218. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  219. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  220. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  221. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  222. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  223. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  224. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  225. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  226. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  227. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  228. Elazar A, et al. 2022. Elife. 11:. PubMed
  229. Berube A, et al. 2022. Viruses. 14:. PubMed
  230. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  231. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  232. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  233. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  234. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  235. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  236. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  237. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  238. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  239. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  240. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  241. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  242. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  243. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  244. Chen J, et al. 2008. Blood. 111:5163. PubMed
  245. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  246. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  247. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  248. Wei H, et al. 2021. Malar J. 20:89. PubMed
  249. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  250. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  251. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  252. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  253. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  254. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  255. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  256. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  257. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  258. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  259. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  260. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  261. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  262. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  263. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  264. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  265. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  266. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  267. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  268. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  269. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  270. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  271. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  272. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  273. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  274. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  275. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  276. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  277. Das S, et al. 2019. Oncogene. 383316. PubMed
  278. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  279. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  280. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  281. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  282. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  283. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  284. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  285. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  286. Marangoni F, et al. 2021. Cell. . PubMed
  287. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  288. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  289. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  290. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  291. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  292. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  293. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  294. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  295. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  296. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  297. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  298. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  299. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  300. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  301. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  302. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  303. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  304. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  305. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  306. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  307. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  308. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  309. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  310. Zheng J, et al. 2020. bioRxiv. . PubMed
  311. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  312. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  313. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  314. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  315. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  316. França TT, et al. 2021. JCI Insight. 6:. PubMed
  317. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  318. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  319. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  320. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  321. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  322. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  323. Zheng J, et al. 2020. Nature. . PubMed
  324. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  325. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  326. Gough D, et al. 2014. Blood. 124:2252. PubMed
  327. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  328. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  329. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  330. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  331. Giampazolias E, et al. 2021. Cell. . PubMed
  332. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  333. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  334. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  335. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  336. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  337. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  338. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  339. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  340. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  341. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  342. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  343. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  344. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  345. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  346. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  347. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  348. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  349. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  350. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  351. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  352. Koide S, et al. 2022. iScience. 25:103603. PubMed
  353. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  354. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  355. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  356. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  357. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  358. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  359. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  360. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  361. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  362. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  363. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  364. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  365. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  366. Li H, et al. 2022. iScience. 25:104481. PubMed
  367. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  368. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  369. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  370. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  371. Zhang B, et al. 2021. Nature. 599:471. PubMed
  372. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  373. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  374. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  375. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  376. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  377. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  378. Yang H, et al. 2022. Viruses. 14:. PubMed
  379. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  380. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  381. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  382. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  383. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  384. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  385. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  386. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_312753 (BioLegend Cat. No. 100714)
AB_312752 (BioLegend Cat. No. 100713)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
    C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100714 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100713 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  2. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  3. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  4. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  5. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  6. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  7. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  8. Ke F, et al. 2023. Elife. 12:. PubMed
  9. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  10. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  11. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  12. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  13. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  14. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  15. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  16. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  17. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  18. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  19. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  20. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  21. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  22. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  23. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  24. Qu L, et al. 2022. Cell. 185:1728. PubMed
  25. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  26. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  27. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  28. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  29. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  30. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  31. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  32. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  33. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  34. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  35. Elazar A, et al. 2022. Elife. 11:. PubMed
  36. Berube A, et al. 2022. Viruses. 14:. PubMed
  37. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  38. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  39. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  40. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  41. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  42. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  43. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  44. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  45. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  46. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  47. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  48. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  49. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  50. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  51. Chen J, et al. 2008. Blood. 111:5163. PubMed
  52. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  53. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  54. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  55. Wei H, et al. 2021. Malar J. 20:89. PubMed
  56. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  57. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  58. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  59. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  60. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  61. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  62. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  63. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  64. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  65. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  66. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  67. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  68. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  69. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  70. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  71. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  72. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  73. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  74. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  75. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  76. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  77. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  78. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  79. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  80. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  81. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  82. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  83. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  84. Das S, et al. 2019. Oncogene. 383316. PubMed
  85. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  86. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  87. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  88. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  89. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  90. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  91. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  92. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  93. Marangoni F, et al. 2021. Cell. . PubMed
  94. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  95. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  96. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  97. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  98. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  99. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  100. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  101. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  102. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  103. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  104. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  105. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  106. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  107. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  108. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  109. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  110. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  111. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  112. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  113. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  114. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  115. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  116. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  117. Zheng J, et al. 2020. bioRxiv. . PubMed
  118. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  119. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  120. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  121. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  122. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  123. França TT, et al. 2021. JCI Insight. 6:. PubMed
  124. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  125. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  126. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  127. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  128. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  129. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  130. Zheng J, et al. 2020. Nature. . PubMed
  131. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  132. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  133. Gough D, et al. 2014. Blood. 124:2252. PubMed
  134. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  135. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  136. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  137. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  138. Giampazolias E, et al. 2021. Cell. . PubMed
  139. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  140. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  141. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  142. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  143. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  144. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  145. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  146. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  147. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  148. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  149. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  150. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  151. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  152. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  153. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  154. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  155. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  156. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  157. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  158. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  159. Koide S, et al. 2022. iScience. 25:103603. PubMed
  160. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  161. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  162. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  163. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  164. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  165. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  166. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  167. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  168. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  169. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  170. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  171. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  172. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  173. Li H, et al. 2022. iScience. 25:104481. PubMed
  174. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  175. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  176. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  177. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  178. Zhang B, et al. 2021. Nature. 599:471. PubMed
  179. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  180. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  181. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  182. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  183. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  184. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  185. Yang H, et al. 2022. Viruses. 14:. PubMed
  186. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  187. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  188. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  189. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  190. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  191. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  192. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  193. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  194. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  195. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  196. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  197. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  198. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  199. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  200. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  201. Ke F, et al. 2023. Elife. 12:. PubMed
  202. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  203. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  204. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  205. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  206. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  207. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  208. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  209. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  210. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  211. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  212. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  213. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  214. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  215. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  216. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  217. Qu L, et al. 2022. Cell. 185:1728. PubMed
  218. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  219. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  220. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  221. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  222. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  223. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  224. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  225. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  226. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  227. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  228. Elazar A, et al. 2022. Elife. 11:. PubMed
  229. Berube A, et al. 2022. Viruses. 14:. PubMed
  230. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  231. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  232. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  233. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  234. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  235. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  236. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  237. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  238. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  239. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  240. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  241. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  242. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  243. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  244. Chen J, et al. 2008. Blood. 111:5163. PubMed
  245. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  246. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  247. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  248. Wei H, et al. 2021. Malar J. 20:89. PubMed
  249. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  250. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  251. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  252. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  253. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  254. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  255. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  256. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  257. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  258. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  259. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  260. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  261. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  262. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  263. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  264. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  265. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  266. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  267. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  268. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  269. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  270. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  271. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  272. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  273. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  274. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  275. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  276. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  277. Das S, et al. 2019. Oncogene. 383316. PubMed
  278. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  279. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  280. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  281. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  282. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  283. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  284. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  285. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  286. Marangoni F, et al. 2021. Cell. . PubMed
  287. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  288. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  289. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  290. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  291. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  292. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  293. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  294. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  295. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  296. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  297. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  298. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  299. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  300. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  301. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  302. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  303. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  304. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  305. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  306. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  307. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  308. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  309. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  310. Zheng J, et al. 2020. bioRxiv. . PubMed
  311. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  312. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  313. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  314. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  315. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  316. França TT, et al. 2021. JCI Insight. 6:. PubMed
  317. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  318. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  319. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  320. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  321. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  322. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  323. Zheng J, et al. 2020. Nature. . PubMed
  324. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  325. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  326. Gough D, et al. 2014. Blood. 124:2252. PubMed
  327. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  328. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  329. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  330. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  331. Giampazolias E, et al. 2021. Cell. . PubMed
  332. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  333. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  334. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  335. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  336. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  337. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  338. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  339. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  340. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  341. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  342. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  343. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  344. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  345. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  346. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  347. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  348. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  349. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  350. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  351. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  352. Koide S, et al. 2022. iScience. 25:103603. PubMed
  353. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  354. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  355. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  356. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  357. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  358. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  359. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  360. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  361. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  362. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  363. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  364. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  365. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  366. Li H, et al. 2022. iScience. 25:104481. PubMed
  367. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  368. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  369. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  370. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  371. Zhang B, et al. 2021. Nature. 599:471. PubMed
  372. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  373. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  374. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  375. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  376. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  377. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  378. Yang H, et al. 2022. Viruses. 14:. PubMed
  379. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  380. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  381. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  382. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  383. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  384. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  385. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  386. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_312753 (BioLegend Cat. No. 100714)
AB_312752 (BioLegend Cat. No. 100713)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account